MedPath

Predictive Factors and Outcome in Medical Thoracoscopy

Completed
Conditions
Pleuritis
Interventions
Drug: sterile talc pleurodesis
Registration Number
NCT02288065
Lead Sponsor
KU Leuven
Brief Summary

Retrospective survey for factors predicting the outcome of medical thoracoscopy

Detailed Description

Retrospective survey for factors predicting the outcome of medical thoracoscopy in patients with malignant pleuritis

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
155
Inclusion Criteria
  • progressive malignancy
  • pleuritis
Exclusion Criteria
  • respiratory failure
  • unable to consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
responderssterile talc pleurodesisamelioration of dyspnea radiological amelioration after sterile talc pleurodesis
failed interventionsterile talc pleurodesisunchanged symptoms and radiology after sterile talc pleurodesis
Primary Outcome Measures
NameTimeMethod
Chest X-ray3 months

radiological resolution of pleuritis; 3 level severity grading (A, B, C, with C as worst grade)

Secondary Outcome Measures
NameTimeMethod
time interval12 months

survival in months

Trial Locations

Locations (1)

UZ Leuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath